Abstract: Ethyl pyridine-4-carboxylate (1) treated with hydrazine hydrate in methanol give pyridine-4-carboxy hydrazide (2). Compound 2 react with substituted aroyl chlorides affords N-substituted aroyl pyridine-4-carbonyl hydrazines (3-9), which on treatment with POCl 3 yield 2(substituted phenyl)-5-(pyridine-4-yl)-1,3,4-oxadiazoles (10-16). The newly synthesized compounds 10-16 were confirmed by elemental (C, H, N) and spectral (IR, 1 H NMR and mass) analysis. Compounds 10-16 have been tested for their antibacterial activity using ampicillin as a reference compound.
Introduction
Heterocyclic system containing pyridine ring, constitute an important class of potentially bioactive compounds. The earlier workers reported that, pyridine derivatives are associated with a wide spectrum of biological activities viz antimicrobial 1-2 , anti-inflammatory 3 , antibacterial 4 , anti-parkinsonian 5 , anticonvulsant 6 , analgesic 7 etc. Similarly oxadiazole have shown a wide range of applications in drug development against convulsant 8 , inflammatory 9 , bacterial [10] [11] and microbial [12] [13] etc. It is therefore thought worthwhile to synthesize some pyridine derivatives contain oxadiazole moiety with the hope to possess better antibacterial activity.
Experimental
The melting points of compounds were determined in open capillaries with the help of thermionic melting point apparatus and were uncorrected. The homogeneity of newly synthesized compounds was routinely checked by thin layer chromatography (TLC) Elemental analysis (C, H, N) of the synthesized compounds were determined by PerkinElmer 2400 elemental analyzer, and results were found within the ±0.4% of theoretical values.
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Chem Sci Trans., 2015, 4(1), [133] [134] [135] [136] The IR spectra were recorded on a Beckman Acculab-10 Spectrometer (ν max in cm -1 ) and the 1 H NMR spectra were recorded by Brucker DPX-300MHz using CDCl 3 as solvent. Mass spectra were determined on VG-70-S instrument. The synthesis of the target compounds was accomplished according to the reaction sequence illustrated in Scheme 1. 
Synthesis of ethyl-4-pyridinoate (1)
To a solution of pyridine-4-carboxylic acid (0.15 mol), dry DMF and ethyl iodide (0.15 mol) was added drop wise in 500 mL round bottom flask. The reaction mixture was stirred for 2-3 h at 20-25 0 C, reaction monitored by technique up to completion. After the reaction completed, ice water was added and stirred for 30 min. The precipitate was collected by filtration technique, washed with water and recrystallized from ethanol to yield compound 1.
Synthesis of pyridine-4-yl-carbonyl hydrazide (2)
Dissolved the ethyl-4-pyridinoate (0.1 mol) in 30 mL of methanol and hydrazine hydrate (0.1 mol) was added drop wise to mixture with stirring. The resulting mixture was allowed to reflux for 8 h. Excess of methanol was distilled out and the content was allowed to cool. The crystal formed was filtered, washed thoroughly with water, dried and recrystallized from methanol to afford compound 2.
General procedure for the preparation of N-substituted benzoyl pyridin-4-yl-carbonyl hydrazide (3-9)
A mixture of compound 2 (0.1 mol) in dry ether, substituted benzoyl chloride (0.2 mol) were added with stirring for 7 h. The reaction mixtures were refluxed for 6 h on water bath. The solvent was distilled off and the reaction mixtures were poured on to crushed ice. The solids thus obtained were filtered and re-crystallized from ethanol to yield compounds 3-9.
General procedure for the preparation of 2-(substituted phenyl)-5-(pyridine-4-yl)-1,3,4-oxadiazoles (10-16)
Compounds 3-9 (0.1 mol) reacted with phosphorous oxychloride (30 mL) and refluxed gently for 30 min and cooled followed by careful addition of water (90 mL). The separated solid was filtered and suspended in water and basified with aqueous potassium hydroxide followed by filtration, drying and crystallization from ethanol to yield compounds 10-16. + at m/z 302.13.
2-(4-Chlorophenyl)-5-(pyridine-4-yl)-1,3,4-oxadiazole (11)
Yield
2-(4-Bromophenyl)-5-(pyridine-4-yl)-1,3,4-oxadiazole (12)
2-(4-Hydroxyphenyl)-5-(pyridine-4-yl)-1,3,4-oxadiazole (13)
Yield 65% (acetone); m.p. 981 
2-(4-Nitrophenyl)-5-(pyridine-4-yl)-1,3,4-oxadiazole (14)
Yield 62% (methanol); m.p. 210 
2-(2,6-dichlorophenyl)-5-(pyridine-4-yl)-1,3,4-oxadiazole (15)
2-(2,6-dibromophenyl)-5-(pyridine-4-yl)-1,3,4-oxadiazole (16)
Results and Discussion
The compounds 10-16 were screened for their antibacterial activity against the bacteria S. aureus, E. coli, P. vulgaris and K. pneumonia following the cup plate method 14 at 250 µg/mL concentrations. The results are given in Table 1 . The compounds 11 and 14 exhibiting good activity against all different bacteria. Among the compounds 10-16, compounds 15 and 16 exhibited potent antibacterial activity than standard drug ampicillin against S. aureus, E. coli, P. vulgaris and K. pneumonia. All the remaining compounds exhibited moderate activity against all the organism used for screening. 
Conclusion
The successful synthesis of series of heterocyclic compounds and evaluation of the antibacterial activity of oxadiazole derivatives of pyridine were reported. 2,6-Dichlorogroup in oxadiazole ring showed more efficiency due to presence of more electronegative atom.
